Genprex, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Apr. 1, 2024).

Předmět:
Zdroj: Pharma Business Week; 4/16/2024, p1809-1809, 1p
Abstrakt: Genprex, Inc., a biopharmaceutical company, has filed a Form 10-K with the U.S. Securities and Exchange Commission (SEC). The filing provides a comprehensive overview of the company's business and must be submitted within 90 days after the end of the fiscal year. The contact information for Genprex, Inc. is located in Austin, Texas. This news article provides additional information about the SEC filing and includes keywords such as biopharmaceutical companies and healthcare biotechnology companies. [Extracted from the article]
Databáze: Complementary Index